|
Market Closed -
Sao Paulo
06:53:36 10/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 74.27 BRL | -0.71% |
|
+3.15% | +12.60% |
| 13/10 | Amgen's Q3 Results Should Reflect Continued Commercial Momentum, BofA Securities Says | MT |
| 12/10 | BofA Securities Adjusts Amgen Price Target to $328 From $317, Maintains Underperform Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Amgen Inc.(AMGN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Amgen Inc.(AMGN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Amgen Inc.(AMGN)
EBIT
Dividend / Share (DPS)
Data source:
Amgen Inc.(AMGN)
Cash or Net Debt
- Stock Market
- Stocks
- AMGN Stock
- AMGN34 Stock
- Consensus Amgen Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
